VRx@Home
Interventional Study
Get in touch about this studyFull study title: A virtual reality at-home intervention for persons living with dementia and their caregivers
What is the study about?
VRx@Home is a 5-week virtual reality (VR) at-home intervention that explores whether VR experiences can enhance communication between persons living with dementia and their family/friend caregivers. This study will also explore how a head-mounted VR system, which provides a fully immersive experience, compares to tablet-based technology. Individuals living with dementia and their family/friend caregiver will watch a series of 360-degree videos together, such as concert, sporting events, and travel destinations, and then answer questions regarding their experience.
Eligibility- Who can participate?
Pairs of people consisting of:
- A person living with mild-to-moderate dementia who is living at home.
And
- A friend/family caregiver above the age of 18, who speaks and understands English and is willing to also participate in the intervention.
- Participants must reside in Greater Toronto Area (Toronto, Peel, Halton, York, and Durham regions).
- Person living with dementia cannot have a history of stroke, bypass surgery, seizure disorders, or cervical conditions or face wounds that would make it unsafe for them to wear the VR headset.
Time requirement
The entire intervention will be 5 weeks long, and it will take approximately 3 hours per week. Each week, sessions with the researcher will be about 2-hours long, with an additional 1-hour of independent watching. Equipment drop-off and training sessions will be done in person at the participants’ home. The weekly intervention sessions with the researchers will all be conducted virtually. During these sessions, interpersonal interactions between the person living with dementia and their caregiver will be video recorded through video-conferencing software.
TDRA study investigator
Dr. Jennifer Campos, Dr. Raheleh Saryazdi
TDRA Site:
Participate from home
Age Group:
18 - 24, 25 - 29, 30 - 39, 40 - 49, 50 - 54, 55 - 59, 60 - 64, 65 - 69, 70 - 80, 81 - 85, 86 - 90, 91+
Target Population:
Alzheimer’s disease, Caregivers, Dementia with Lewy bodies (DLB), Frontotemporal dementia (FTD), Lewy Body Dementia (LBD), Memory Loss without a Diagnosis of Dementia, Mild Dementia, Moderate Dementia, Parkinson's disease-related dementia, Vascular dementia